|
|
Volumn 56, Issue 9, 1999, Pages 1059-1060
|
|
When should heparin be given to patients with atrial fibrillation- related embolic brain infarcts?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALTEPLASE;
HEPARIN;
PLACEBO;
THROMBOPLASTIN;
ANTICOAGULANT THERAPY;
BRAIN EMBOLISM;
BRAIN HEMORRHAGE;
BRAIN INFARCTION;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG EFFECT;
DRUG SAFETY;
EDITORIAL;
FIBRINOLYTIC THERAPY;
HEART ATRIUM FIBRILLATION;
HEPARINIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
CEREBRAL INFARCTION;
DECISION MAKING;
DRUG ADMINISTRATION SCHEDULE;
DRUG UTILIZATION;
HEPARIN;
HUMANS;
INTRACRANIAL EMBOLISM AND THROMBOSIS;
PATIENT SELECTION;
RECURRENCE;
RISK;
TREATMENT OUTCOME;
|
|
EID: 0032888128
PISSN: 00039942
EISSN: None
Source Type: Journal
DOI: 10.1001/archneur.56.9.1059 Document Type: Editorial |
|
Times cited : (10)
|
|
References (9)
|
